Access Statistics for Moritz Suppliet

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Co-Payment Exemptions and Reference Prices: an Empirical Study of Pharmaceutical Prices in Germany 0 0 2 35 1 6 17 383
Cost-Sharing and Drug Pricing Strategies: Introducing Tiered Co-Payments in Reference Price Markets 0 0 1 1 0 1 8 20
Cost-Sharing and Drug Pricing Strategies: Introducing Tiered Co-Payments in Reference Price Markets 0 0 0 1 0 4 10 15
Cost-Sharing and Drug Pricing Strategies: Introducing Tiered Co-Payments in Reference Price Markets 0 0 0 70 0 3 6 88
Cost-Sharing and Drug Pricing Strategies: Introducing Tiered Co-Payments in Reference Price Markets 0 0 0 42 0 4 13 105
Pharmaceutical prices under regulation: Tiered co-payments and reference pricing in Germany 0 0 2 240 0 5 35 953
The Welfare Impact of Parallel Imports: A Structural Approach Applied to the German Market for Oral Anti-Diabetics 0 0 1 31 1 4 19 167
The Welfare Impact of Parallel Imports: A Structural Approach Applied to the German Market for Oral Anti-diabetics 0 0 0 19 1 3 12 104
The welfare impact of parallel imports: A structural approach applied to the German market for oral anti-diabetics 0 0 0 51 0 3 11 227
The welfare impact of parallel imports: A structural approach applied to the German market for oral antidiabetics 0 0 0 30 2 5 20 120
Umbrella Branding in Pharmaceutical Markets 0 0 0 1 0 2 13 29
Umbrella Branding in Pharmaceutical Markets 0 0 0 1 1 4 17 35
Umbrella Branding in Pharmaceutical Markets 0 0 0 51 0 1 9 89
Umbrella Branding in Pharmaceutical Markets 0 1 1 91 0 4 11 244
Vergleichbarkeit internationaler Arzneimittelpreise: Internationale Preisreferenzierung in Deutschland durch das AMNOG 0 2 2 42 0 4 11 292
Total Working Papers 0 3 9 706 6 53 212 2,871


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
THE WELFARE IMPACT OF PARALLEL IMPORTS: A STRUCTURAL APPROACH APPLIED TO THE GERMAN MARKET FOR ORAL ANTI‐DIABETICS 0 0 0 18 1 3 10 112
Tiered co-payments, pricing, and demand in reference price markets for pharmaceuticals 0 0 0 7 1 5 13 60
Umbrella branding in pharmaceutical markets 0 0 1 12 0 4 13 141
Vergleichbarkeit internationaler Arzneimittelpreise: Internationale Preisreferenzierung in Deutschland durch das AMNOG 0 0 2 9 0 4 11 79
Total Journal Articles 0 0 3 46 2 16 47 392


Statistics updated 2026-07-10